US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 1.405
  • -0.015-1.06%
Trading Apr 26 12:27 ET
77.18MMarket Cap-534P/E (TTM)

Marinus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
21.63%30.99M
0.39%7.19M
213.59%7.34M
239.72%6.08M
-26.83%10.38M
66.03%25.48M
371.18%7.16M
-76.86%2.34M
-6.04%1.79M
685.49%14.19M
Operating revenue
21.63%30.99M
0.39%7.19M
213.59%7.34M
239.72%6.08M
-26.83%10.38M
66.03%25.48M
371.18%7.16M
-76.86%2.34M
-6.04%1.79M
685.49%14.19M
Cost of revenue
468.82%1.93M
203.77%887K
847.92%455K
386K
206K
-77.00%340K
292K
-96.75%48K
0
0
Gross profit
15.58%29.06M
-8.25%6.3M
200.31%6.88M
218.16%5.7M
-28.28%10.17M
81.28%25.14M
351.97%6.87M
-73.46%2.29M
1.79M
14.19M
Operating expense
16.40%160.54M
15.68%41.74M
18.95%38.53M
-3.69%37.13M
39.62%43.14M
24.48%137.93M
26.00%36.08M
16.49%32.39M
51.86%38.56M
6.66%30.9M
Selling and administrative expenses
7.58%61.15M
4.78%15.36M
11.05%14.87M
-7.85%15.72M
29.54%15.2M
52.49%56.85M
38.00%14.66M
41.65%13.39M
149.87%17.06M
13.12%11.74M
Research and development costs
24.37%99.39M
23.14%26.38M
24.52%23.66M
-0.39%21.41M
55.26%27.93M
8.69%79.91M
18.93%21.42M
3.54%19M
15.80%21.5M
-3.23%17.99M
Other operating expenses
----
----
----
----
----
--1.17M
--0
----
----
--1.17M
Operating profit
-16.58%-131.49M
-21.31%-35.44M
-5.14%-31.65M
14.49%-31.44M
-97.25%-32.96M
-16.36%-112.79M
-7.73%-29.21M
-57.02%-30.1M
-56.55%-36.77M
38.47%-16.71M
Net non-operating interest income expense
-5.58%-8.78M
-31.09%-2.55M
-10.71%-2.35M
19.13%-2.08M
-7.38%-1.8M
-232.45%-8.32M
-27.19%-1.95M
-220.73%-2.12M
-667.76%-2.57M
-7,100.00%-1.68M
Non-operating interest income
244.65%8.11M
0.17%1.75M
268.68%1.9M
2,433.33%2.13M
19,425.00%2.34M
2,842.50%2.35M
7,482.61%1.74M
2,923.53%514K
425.00%84K
-50.00%12K
Non-operating interest expense
58.31%16.9M
16.48%4.3M
61.05%4.24M
58.43%4.21M
145.09%4.15M
313.32%10.67M
137.60%3.69M
288.50%2.63M
656.70%2.66M
--1.69M
Other net income (expense)
-102.56%-2.68M
-149.24%-3.78M
-99.05%1.02M
149.47%47K
103.81%37K
15,832.88%104.68M
-544.87%-1.52M
33,107.74%107.26M
-3,066.67%-95K
-24,150.00%-970K
Other non- operating income (expenses)
-102.56%-2.68M
-149.24%-3.78M
-99.05%1.02M
149.47%47K
103.81%37K
15,832.88%104.68M
-544.87%-1.52M
33,107.74%107.26M
-3,066.67%-95K
-24,150.00%-970K
Income before tax
-770.17%-142.94M
-27.83%-41.77M
-143.94%-32.97M
15.12%-33.47M
-79.38%-34.73M
83.37%-16.43M
-15.44%-32.68M
484.69%75.04M
-65.52%-39.43M
28.67%-19.36M
Income tax
-145.38%-1.54M
0
0
-1.54M
3.39M
1.64M
1.75M
0
Net income
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
475.71%73.29M
-65.52%-39.43M
28.67%-19.36M
Net income continuous Operations
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
475.71%73.29M
-65.52%-39.43M
28.67%-19.36M
Minority interest income
Net income attributable to the parent company
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
475.71%73.29M
-65.52%-39.43M
28.67%-19.36M
Preferred stock dividends
1.66M
Other preferred stock dividends
Net income attributable to common stockholders
-613.59%-141.41M
-22.94%-41.77M
-146.03%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-20.04%-33.98M
467.22%71.63M
-65.52%-39.43M
28.67%-19.36M
Basic earnings per share
-415.69%-2.63
2.63%-0.74
-131.61%-0.61
42.45%-0.61
-28.85%-0.67
81.04%-0.51
1.30%-0.76
464.15%1.93
-63.08%-1.06
29.73%-0.52
Diluted earnings per share
-415.69%-2.63
2.63%-0.74
-132.28%-0.61
42.45%-0.61
-28.85%-0.67
81.04%-0.51
1.30%-0.76
456.60%1.89
-63.08%-1.06
29.73%-0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 21.63%30.99M0.39%7.19M213.59%7.34M239.72%6.08M-26.83%10.38M66.03%25.48M371.18%7.16M-76.86%2.34M-6.04%1.79M685.49%14.19M
Operating revenue 21.63%30.99M0.39%7.19M213.59%7.34M239.72%6.08M-26.83%10.38M66.03%25.48M371.18%7.16M-76.86%2.34M-6.04%1.79M685.49%14.19M
Cost of revenue 468.82%1.93M203.77%887K847.92%455K386K206K-77.00%340K292K-96.75%48K00
Gross profit 15.58%29.06M-8.25%6.3M200.31%6.88M218.16%5.7M-28.28%10.17M81.28%25.14M351.97%6.87M-73.46%2.29M1.79M14.19M
Operating expense 16.40%160.54M15.68%41.74M18.95%38.53M-3.69%37.13M39.62%43.14M24.48%137.93M26.00%36.08M16.49%32.39M51.86%38.56M6.66%30.9M
Selling and administrative expenses 7.58%61.15M4.78%15.36M11.05%14.87M-7.85%15.72M29.54%15.2M52.49%56.85M38.00%14.66M41.65%13.39M149.87%17.06M13.12%11.74M
Research and development costs 24.37%99.39M23.14%26.38M24.52%23.66M-0.39%21.41M55.26%27.93M8.69%79.91M18.93%21.42M3.54%19M15.80%21.5M-3.23%17.99M
Other operating expenses ----------------------1.17M--0----------1.17M
Operating profit -16.58%-131.49M-21.31%-35.44M-5.14%-31.65M14.49%-31.44M-97.25%-32.96M-16.36%-112.79M-7.73%-29.21M-57.02%-30.1M-56.55%-36.77M38.47%-16.71M
Net non-operating interest income expense -5.58%-8.78M-31.09%-2.55M-10.71%-2.35M19.13%-2.08M-7.38%-1.8M-232.45%-8.32M-27.19%-1.95M-220.73%-2.12M-667.76%-2.57M-7,100.00%-1.68M
Non-operating interest income 244.65%8.11M0.17%1.75M268.68%1.9M2,433.33%2.13M19,425.00%2.34M2,842.50%2.35M7,482.61%1.74M2,923.53%514K425.00%84K-50.00%12K
Non-operating interest expense 58.31%16.9M16.48%4.3M61.05%4.24M58.43%4.21M145.09%4.15M313.32%10.67M137.60%3.69M288.50%2.63M656.70%2.66M--1.69M
Other net income (expense) -102.56%-2.68M-149.24%-3.78M-99.05%1.02M149.47%47K103.81%37K15,832.88%104.68M-544.87%-1.52M33,107.74%107.26M-3,066.67%-95K-24,150.00%-970K
Other non- operating income (expenses) -102.56%-2.68M-149.24%-3.78M-99.05%1.02M149.47%47K103.81%37K15,832.88%104.68M-544.87%-1.52M33,107.74%107.26M-3,066.67%-95K-24,150.00%-970K
Income before tax -770.17%-142.94M-27.83%-41.77M-143.94%-32.97M15.12%-33.47M-79.38%-34.73M83.37%-16.43M-15.44%-32.68M484.69%75.04M-65.52%-39.43M28.67%-19.36M
Income tax -145.38%-1.54M00-1.54M3.39M1.64M1.75M0
Net income -613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M475.71%73.29M-65.52%-39.43M28.67%-19.36M
Net income continuous Operations -613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M475.71%73.29M-65.52%-39.43M28.67%-19.36M
Minority interest income
Net income attributable to the parent company -613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M475.71%73.29M-65.52%-39.43M28.67%-19.36M
Preferred stock dividends 1.66M
Other preferred stock dividends
Net income attributable to common stockholders -613.59%-141.41M-22.94%-41.77M-146.03%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-20.04%-33.98M467.22%71.63M-65.52%-39.43M28.67%-19.36M
Basic earnings per share -415.69%-2.632.63%-0.74-131.61%-0.6142.45%-0.61-28.85%-0.6781.04%-0.511.30%-0.76464.15%1.93-63.08%-1.0629.73%-0.52
Diluted earnings per share -415.69%-2.632.63%-0.74-132.28%-0.6142.45%-0.61-28.85%-0.6781.04%-0.511.30%-0.76456.60%1.89-63.08%-1.0629.73%-0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg